Skip to main content

Table 1 Susceptibility patterns of the rare bacteria isolated from blood cultures of febrile cancer patients at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia; December 2011 and June 2012

From: Rare bacterial isolates causing bloodstream infections in Ethiopian patients with cancer

 

Antimicrobial drugs, n (%)

Organisms

 

AMC

AMP

C

CRO

SXT

TTC

CIP

NA

CN

Aeromonas hydrophilia (n=4)

S

-

-

1 (25)

1 (25)

-

-

3 (75)

2 (50)

4 (100)

I

-

-

1 (25)

-

-

1 (25)

-

-

-

R

4 (100)

4 (100)

2 (50)

3 (75)

4 (100)

3 (75)

1 (25)

2 (50)

-

Chryseomonas luteola (n=2)

S

-

-

-

-

-

2 (100)

2 (100)

2 (100)

2 (100)

I

-

-

-

-

-

-

-

-

 

R

2 (100)

2 (100)

2 (100)

2 (100)

2 (100)

-

-

-

-

Pseudomonas fluorescens (n=2)

S

-

-

1 (50)

2 (100)

 

1 (50)

1 (50)

1 (50)

2 (100)

I

-

-

-

-

-

-

-

-

-

R

2 (100)

2 (100)

1 (50)

-

2 (100)

1 (50)

1 (50)

1 (50)

-

Serracia ficaria (n=1)

S

1 (100)

1 (100)

1 (100)

-

1 (100)

1 (100)

1 (100)

-

-

I

-

-

-

-

-

-

-

-

 

R

-

-

-

-

-

1 (100)

-

-

1 (100)

Total (n = 9)

S

1 (11.1)

1 (11.1)

3 (33.3)

 

1 (11.1)

3 (33.3)

7 (77.8)

5 (62.5)a

8 (88.9)

I

-

-

1 (11.1)

 

-

1 (11.1

-

-

 

R

8 (88.9)

8 (88.9)

5 (55.6)

 

8 (88.9)

5 (55.5)

2 (22.2)

3 (37.5)a

1 (11.1)

  1. a= the denominator is 8, S Sensitive, I Intermediate, R Resistant, AMC Amoxicillin-clavulanic acid, AMP Ampicillin, C Chloramphenicol, CRO Ceftriaxone, SXT Trimethoprim-sulphamethoxazole, TTC Teteracycline, CIP Ciprofloxacin GN Gentamycin, NA Nalidixic acid